开云app官网登录入口网页版-官方正版

#EASL#

81篇内容 | 2085人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1412556, encodeId=deb2141255692, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL专家立场声明：慢性肝病、肝胆恶性肿瘤及肝移植受者是否可接种新冠疫苗？, objectType=article, longId=215042, objectId=868021504278, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868021504278, replyNumber=0, likeNumber=68, createdTime=2021-07-31, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868021504278, moduleTitle=EASL专家立场声明：慢性肝病、肝胆恶性肿瘤及肝移植受者是否可接种新冠疫苗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=868021504278)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412555, encodeId=93861412555f4, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2019 EASL临床实践指南：职业性肝病, objectType=article, longId=180246, objectId=1f46180246d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f46180246d3, replyNumber=0, likeNumber=48, createdTime=2019-09-30, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f46180246d3, moduleTitle=2019 EASL临床实践指南：职业性肝病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1f46180246d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412554, encodeId=8f871412554e6, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL：VEGFR2单抗Ramucirumab对晚期肝细胞癌的治疗有临床益处, objectType=article, longId=164528, objectId=3745164528c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3745164528c3, replyNumber=0, likeNumber=68, createdTime=2019-04-20, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3745164528c3, moduleTitle=EASL：VEGFR2单抗Ramucirumab对晚期肝细胞癌的治疗有临床益处, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3745164528c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412553, encodeId=036a1412553ab, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2019 EASL临床实践指南：药物性肝损伤, objectType=article, longId=164516, objectId=1ddd1645161b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ddd1645161b, replyNumber=0, likeNumber=56, createdTime=2019-04-19, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ddd1645161b, moduleTitle=2019 EASL临床实践指南：药物性肝损伤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1ddd1645161b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412552, encodeId=d35a14125520c, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, objectType=article, longId=164365, objectId=dbfc16436511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbfc16436511, replyNumber=0, likeNumber=67, createdTime=2019-04-17, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbfc16436511, moduleTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dbfc16436511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412551, encodeId=6d7414125513d, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据, objectType=article, longId=164220, objectId=392016422049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=392016422049, replyNumber=0, likeNumber=67, createdTime=2019-04-15, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=392016422049, moduleTitle=2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=392016422049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412550, encodeId=28301412550ad, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2018 EASL临床实践指南：慢性肝病患者的营养, objectType=article, longId=147651, objectId=ce5214e6513d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce5214e6513d, replyNumber=0, likeNumber=62, createdTime=2018-08-30, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce5214e6513d, moduleTitle=2018 EASL临床实践指南：慢性肝病患者的营养, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ce5214e6513d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412549, encodeId=0210141254924, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=Diabetic Med：欧洲肝脏研究协会（EASL），欧洲糖尿病研究协会（EASD）和欧洲肥胖研究协会（EASO）对非酒精性脂肪性肝病管理临床实践建议如何？, objectType=article, longId=142463, objectId=6091142463a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6091142463a1, replyNumber=0, likeNumber=0, createdTime=2018-07-06, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6091142463a1, moduleTitle=Diabetic Med：欧洲肝脏研究协会（EASL），欧洲糖尿病研究协会（EASD）和欧洲肥胖研究协会（EASO）对非酒精性脂肪性肝病管理临床实践建议如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6091142463a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412548, encodeId=e4b014125484c, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2018 EASL建议：丙型肝炎的治疗, objectType=article, longId=135794, objectId=0852135e944b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0852135e944b, replyNumber=0, likeNumber=60, createdTime=2018-04-20, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0852135e944b, moduleTitle=2018 EASL建议：丙型肝炎的治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0852135e944b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412547, encodeId=6d33141254eb8, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL临床实践指南：失代偿性肝硬化患者的管理, objectType=article, longId=135570, objectId=c1481355e018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1481355e018, replyNumber=0, likeNumber=58, createdTime=2018-04-18, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1481355e018, moduleTitle=EASL临床实践指南：失代偿性肝硬化患者的管理, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c1481355e018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412546, encodeId=f2901412546f5, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2018 EASL临床实践指南：酒精性肝病的管理, objectType=article, longId=135326, objectId=76a0135326cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76a0135326cc, replyNumber=0, likeNumber=67, createdTime=2018-04-15, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76a0135326cc, moduleTitle=2018 EASL临床实践指南：酒精性肝病的管理, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=76a0135326cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412545, encodeId=fa5f141254582, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2018 EASL临床实践指南：戊型肝炎感染, objectType=article, longId=134548, objectId=5ff0134548df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ff0134548df, replyNumber=0, likeNumber=45, createdTime=2018-04-10, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ff0134548df, moduleTitle=2018 EASL临床实践指南：戊型肝炎感染, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5ff0134548df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412544, encodeId=7d64141254488, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读, objectType=article, longId=110398, objectId=dbd4110398bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd4110398bc, replyNumber=0, likeNumber=47, createdTime=2017-08-23, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd4110398bc, moduleTitle=《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dbd4110398bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412543, encodeId=44d414125431d, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL 2017：肝癌晚期应该怎么办？, objectType=article, longId=97266, objectId=2dcb9e2663a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dcb9e2663a, replyNumber=0, likeNumber=39, createdTime=2017-04-28, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dcb9e2663a, moduleTitle=EASL 2017：肝癌晚期应该怎么办？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2dcb9e2663a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412542, encodeId=bf2414125425b, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=2016EASL建议——丙型肝炎的治疗发布, objectType=article, longId=78931, objectId=84a7e893169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84a7e893169, replyNumber=0, likeNumber=46, createdTime=2016-09-30, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84a7e893169, moduleTitle=2016EASL建议——丙型肝炎的治疗发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=84a7e893169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412541, encodeId=eba41412541b4, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, objectType=article, longId=72155, objectId=4910e2155ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4910e2155ba, replyNumber=0, likeNumber=70, createdTime=2016-07-07, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4910e2155ba, moduleTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4910e2155ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412540, encodeId=af1c1412540c2, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL年会“更佳肝炎研究亮点”国内首次发布, objectType=article, longId=71243, objectId=0614e124337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0614e124337, replyNumber=0, likeNumber=77, createdTime=2016-06-21, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0614e124337, moduleTitle=EASL年会“更佳肝炎研究亮点”国内首次发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0614e124337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412539, encodeId=d4c9141253937, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, objectType=article, longId=70398, objectId=4835e039867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4835e039867, replyNumber=0, likeNumber=73, createdTime=2016-06-11, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4835e039867, moduleTitle=EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4835e039867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412538, encodeId=a71e141253885, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》, objectType=article, longId=51330, objectId=21af51330b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21af51330b4, replyNumber=0, likeNumber=52, createdTime=2015-05-30, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21af51330b4, moduleTitle=EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=21af51330b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412537, encodeId=98a2141253e8a, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, objectTitle=EASL 2015：外显子组测序有助于肝癌个体化治疗, objectType=article, longId=50157, objectId=17a85015efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17a85015efe, replyNumber=0, likeNumber=67, createdTime=2015-05-04, rootId=0, userName=kord1983, userId=a0c52872504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17a85015efe, moduleTitle=EASL 2015：外显子组测序有助于肝癌个体化治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=17a85015efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

EASL

2020-05-29

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL专家立场声明：慢性肝病、肝胆恶性肿瘤及肝移植受者是否可接种新冠疫苗？

2021-07-31

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2019 EASL临床实践指南：职业性肝病

2019-09-30

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL：VEGFR2单抗Ramucirumab对晚期肝细胞癌的治疗有临床益处

2019-04-20

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2019 EASL临床实践指南：药物性肝损伤

2019-04-19

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性

2019-04-17

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2019年欧洲肝脏研究协会（EASL）年会：RNA干扰药物JNJ-3989的临床数据

2019-04-15

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2018 EASL临床实践指南：慢性肝病患者的营养

2018-08-30

kord1983 (审核中...)

前往app查看评论内容

#EASL#

Diabetic Med：欧洲肝脏研究协会（EASL），欧洲糖尿病研究协会（EASD）和欧洲肥胖研究协会（EASO）对非酒精性脂肪性肝病管理临床实践建议如何？

2018-07-06

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2018 EASL建议：丙型肝炎的治疗

2018-04-20

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL临床实践指南：失代偿性肝硬化患者的管理

2018-04-18

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2018 EASL临床实践指南：酒精性肝病的管理

2018-04-15

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2018 EASL临床实践指南：戊型肝炎感染

2018-04-10

kord1983 (审核中...)

前往app查看评论内容

#EASL#

《2017年EASL临床实践指南：乙型肝炎病毒感染的管理》要点解读

2017-08-23

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL 2017：肝癌晚期应该怎么办？

2017-04-28

kord1983 (审核中...)

前往app查看评论内容

#EASL#

2016EASL建议——丙型肝炎的治疗发布

2016-09-30

kord1983 (审核中...)

前往app查看评论内容

#EASL#

近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读

2016-07-07

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL年会“更佳肝炎研究亮点”国内首次发布

2016-06-21

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL 2016：REP 2139治疗HBV/HDV合并感染有疗效

2016-06-11

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL-ALEH 2015《无创检查评估肝脏疾病严重程度及预后临床指南》

2015-05-30

kord1983 (审核中...)

前往app查看评论内容

#EASL#

EASL 2015：外显子组测序有助于肝癌个体化治疗

2015-05-04

科室
- - 订阅+
  - 更多科室
工具
服务